SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors digest record revenue growth and a strong cash position alongside ongoing speculation regarding global commercial expansion and upcoming FDA regulatory catalysts. The community is actively debating the company's long-term fundamentals versus short-term price volatility, with many expressing strong conviction in the firm's pipeline despite heavy short interest.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility as investors weigh a strong growth narrative against persistent stock price pressure near annual lows, fueled by concerns over Alani Nu integration and competitive dynamics. The community is actively debating whether current levels represent an institutional accumulation phase ahead of upcoming earnings or reflect deeper structural headwinds in the energy drink sector.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following the successful closure of a $600 million AAA-rated asset-backed securities transaction, which has bolstered investor confidence in its AI-driven credit underwriting model. The community is currently focused on the stock's potential for a recovery, emphasizing its move toward sustained profitability and the expansion of its institutional partner network despite broader macro-economic and geopolitical headwinds.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trending due to a massive disconnect between its strong fundamentals and recent stock price volatility, with investors debating whether the stock is a 'profit machine' or vulnerable to dilution from a shelf offering. The community is sharply divided, with bulls pointing to record-breaking margins and AI-driven growth, while some bears are signaling caution regarding potential SEC investigation risks and the broader software sector's recent underperformance.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as investors react to a major leadership overhaul and the acquisition of Kezar Life Sciences. The market is actively debating whether these aggressive moves under new management signal an accelerated path toward a potential buyout or a strategic shift in long-term pipeline development.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending following a surge in trading volume and investor interest sparked by a report highlighting its role as a key supplier for AI infrastructure and optics. The community is actively debating the sustainability of this rally, with discussions centered on potential institutional positioning, the impact of heavy call option activity, and the company's long-term integration into advanced data center technologies.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending after receiving a second Complete Response Letter from the FDA for its tabelecleucel therapy, sparking intense debate among retail traders regarding its financial runway and the potential for a long-term turnaround via a Type A meeting path. While some community members view the stock as a distressed asset facing inevitable dilution, others are actively scouting for entry points, citing the drug's established approval in Europe and the possibility of a strategic partnership or buyout.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending due to a significant stock price surge following a strong earnings report that topped expectations for both revenue and customer growth. The community is actively discussing the stock's resilience in the software sector, potential long-term benefits from AI infrastructure demands, and the reliability of its observability platform despite broader concerns about software sector valuations.

Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the Twin Vee PowerCats and Wizz Banger, Inc. Segments. The Twin Vee PowerCats segment designs, manufactures, and sells recreational and commercial powerboats. The Wizz Banger, Inc. segment refers to a development-stage subsidiary with plans to develop an innovative online marketplace leveraging artificial intelligence (AI) to transform how customers search for and purchase recreational marine assets. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.

Twin Vee PowerCats Co

Twin Vee PowerCats Co. is trending following a recent reverse stock split and active insider buying, which has sparked significant community debate regarding potential short squeeze opportunities and valuation discrepancies. Investors are closely monitoring the low-float setup and ongoing volatility, with discussions split between those anticipating a sharp recovery and those wary of recurring dilution risks.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility following an unexpected FAERS report regarding a patient death, which sparked a sharp sell-off before a rapid recovery as the event was deemed unrelated to their treatment. The community remains deeply divided, with bulls pointing to the company's strong revenue and upcoming pipeline readouts as catalysts for a potential short squeeze, while bears continue to highlight regulatory skepticism and skepticism toward the efficacy of their flagship therapy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Keybank National Association OH Grows Stock Position in The J. M. Smucker Company $SJM

Keybank National Association OH boosted its stake in The J. M. Smucker Company (NYSE:SJM - Free Report) by 500.2% in the fourth quarter, according to the company in its most recent 13F filing with...

Ashton Thomas Private Wealth LLC Sells 45,557 Shares of The J. M. Smucker Company $SJM

Ashton Thomas Private Wealth LLC cut its position in The J. M. Smucker Company (NYSE:SJM - Free Report) by 78.5% in the 4th quarter, according to its most recent filing with the Securities and...

The J. M. Smucker Company $SJM Shares Sold by M&T Bank Corp

M&T Bank Corp decreased its holdings in The J. M. Smucker Company (NYSE:SJM - Free Report) by 51.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange...

EL Q3 Earnings on the Horizon: Essential Insights for Investors

EL's fiscal third-quarter results are likely to show sales and earnings growth, though margins may face pressure from tariffs and consumer-facing investments.

The J. M. Smucker Company $SJM Shares Sold by Vest Financial LLC

Vest Financial LLC decreased its position in The J. M. Smucker Company (NYSE:SJM - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange...

UBS Group AG Acquires 2,765,559 Shares of The J. M. Smucker Company $SJM

UBS Group AG lifted its position in shares of The J. M. Smucker Company (NYSE:SJM - Free Report) by 238.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,924,282 shares of the company's stock after purc...

Altria Q1 Earnings on the Horizon: Essential Insights for Investors

MO's first-quarter results are likely to show modest growth, as pricing strength and cost control offset volume declines in smokeable products.

Universal Beteiligungs und Servicegesellschaft mbH Acquires 11,792 Shares of The J. M. Smucker Company $SJM

Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in The J. M. Smucker Company (NYSE:SJM - Free Report) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 131,985 shares of the company's stock after purchasing an addi...

Speece Thorson Capital Group Inc. Sells 34,949 Shares of The J. M. Smucker Company $SJM

Speece Thorson Capital Group Inc. reduced its position in The J. M. Smucker Company (NYSE:SJM - Free Report) by 21.3% during the fourth quarter, according to its most recent 13F filing with the SEC...

Munich Reinsurance Co Stock Corp in Munich Buys New Position in The J. M. Smucker Company $SJM

Munich Reinsurance Co Stock Corp in Munich purchased a new stake in The J. M. Smucker Company (NYSE:SJM - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with...

The J. M. Smucker Co. engages in the manufacture and marketing of food and beverage products. It operates through the following segments: U.S. Retail Coffee, U.S. Retail Frozen Handheld and Spreads, U.S. Retail Pet Foods, and Sweet Baked Snacks. The U.S. Retail Coffee segment includes the domestic sales of Folgers, Dunkin’, and Café Bustelo branded coffee. The U.S. Retail Frozen Handheld and Spreads segment focuses on domestic sales of Smucker’s and Jif branded products. The U.S. Retail Pet Foods segment is involved in the domestic sales of Meow Mix, Milk-Bone, Pup-Peroni, and Canine Carry Outs branded products. The Sweet Baked Snacks segment refers to all domestic and foreign sales of Hostess and Voortman branded products in all channels. The company was founded by Jerome Monroe Smucker in 1897 and is headquartered in Orrville, OH.

J.M. Smucker Co.

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

SJM
J.M. Smucker Co.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SJM News

SJMJ.M. Smucker Co.